Loteprednol Etabonate - NDC Database

11 records found

Page:1

17478-830 Feb 10, 2021
Loteprednol Etabonate 5 mg/g Ophthalmic Gel by Akorn, Inc.

24208-508 Feb 17, 2021
Loteprednol Etabonate 5 mg/g Ophthalmic Gel by Bausch & Lomb Incorporated

50383-265 Apr 18, 2019
Loteprednol Etabonate 5 mg/ml Ophthalmic Suspension/ Drops by Hi-tech Pharmacal Co., Inc.

62756-232 May 01, 2021
Loteprednol Etabonate 5 mg/ml Ophthalmic Suspension/ Drops by Sun Pharmaceutical Industries, Inc.

68682-299 Jul 01, 2019
Loteprednol Etabonate 5 mg/ml Ophthalmic Suspension/ Drops by Oceanside Pharmaceuticals

72485-630 Oct 25, 2023
Loteprednol Etabonate 5 mg/g Ophthalmic Gel by Armas Pharmaceuticals Inc.

72485-653 Oct 24, 2023
Loteprednol Etabonate 2 mg/ml Ophthalmic Suspension/ Drops by Armas Pharmaceuticals Inc.

72485-665 Oct 26, 2023
Loteprednol Etabonate 5 mg/ml Ophthalmic Suspension/ Drops by Armas Pharmaceuticals Inc.

82260-299 Apr 07, 2023
Loteprednol Etabonate 5 mg/ml Ophthalmic Suspension/ Drops by Bausch & Lomb Americas Inc.

82260-361 Feb 09, 2024
Loteprednol Etabonate 2 mg/ml Ophthalmic Suspension/ Drops by Bausch & Lomb Americas Inc.

82260-508 Jun 30, 2023
Loteprednol Etabonate 5 mg/g Ophthalmic Gel by Bausch & Lomb Americas Inc.

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.